Starpharma (ASX:SPL) - CEO, Jackie Fairley
CEO, Jackie Fairley
Source: Starpharma
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Starpharma (SPL) signs an exploratory Dendrimer Drug Delivery (DEP) research agreement with US Biopharma company, Genentech
  • Genetech has an initial focus on evaluating DEP, dendrimer-based drug conjugates
  • Starpharma’s dendrimer-based drug delivery is being used to improve pharmaceuticals, reduce toxicities and enhance their performance
  • The company also has a number of existing DEP partnerships including AstraZeneca, Merck & Co and Chase Sun
  • Company shares are up 5.7 per cent at $1.21 at 10:40 am AEDT

Starpharma (SPL) has signed an exploratory Dendrimer Drug Delivery (DEP) research agreement with US Biopharma company, Genentech.

Genentech is a member of the Roche Group with an initial focus on evaluating DEP, dendrimer-based drug conjugates.

Starpharma’s dendrimer-based drug delivery is being used to improve pharmaceuticals, reduce toxicities and enhance their performance.

The company says the DEP platform has also shown reproducible advantages across a wide range of drug classes and can be utilised with both small molecule drugs, peptides and proteins.

Starpharma also has a number of existing DEP partnerships with leading international pharmaceutical companies for a variety of applications and diseases.

These companies include AstraZeneca, Merck & Co, Chase Sun and other disclosed partnerships.

Starpharma’s DEP technology has already yielded four clinical-stage products.

Company shares are up 5.7 per cent at $1.21 at 10:40 am AEDT.

SPL by the numbers
More From The Market Herald
Nuix (ASX:NXL) - Chairman, Jeffrey Bleich

" Nuix (ASX:NXL) forecast drop in revenue

Global software company Nuix (ASX:NXL) has provided its guidance on financial results for the half-year ended…
ikeGPS (ASX:IKE) - CEO, Glenn Milnes

" ikeGPS (ASX:IKE) signs deal with tier-1 electric utility customer

ikeGPS Group (ASX:IKE) signs a NZ$900,000 (A$841,000) deal following a separate announcement for a $4 million…

" Navarre Minerals (ASX:NML) broad gold zones in first holes at St Arnaud

Navarre Minerals Limited (ASX:NML) reports on its completed drilling program at the St Arnaud Gold Project 240…

" New magnetic anomalies identified Alderan Resources (ASX:AL8) Frisco project

New magnetic anomalies were identified over Alderan Resources (ASX:AL8) Frisco copper-gold-zinc-silver project in Utah, USA.